Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report
Background: Successful treatment of glioblastoma (GBM) remains futile despite decades of intense research. GBM is similar to most other malignant cancers in requiring glucose and glutamine for growth, regardless of histological or genetic heterogeneity. Ketogenic metabolic therapy (KMT) is a non-tox...
Main Authors: | Thomas N. Seyfried, Aditya G. Shivane, Miriam Kalamian, Joseph C. Maroon, Purna Mukherjee, Giulio Zuccoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2021.682243/full |
Similar Items
-
Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer
by: Thomas N. Seyfried, et al.
Published: (2020-03-01) -
Can the Mitochondrial Metabolic Theory Explain Better the Origin and Management of Cancer than Can the Somatic Mutation Theory?
by: Thomas N. Seyfried, et al.
Published: (2021-08-01) -
The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
by: Eric S. Goetzman, et al.
Published: (2018-04-01) -
The emerging role and targetability of the TCA cycle in cancer metabolism
by: Nicole M. Anderson, et al.
Published: (2017-07-01) -
A Metabolic Reprogramming of Glycolysis and Glutamine Metabolism Is a Requisite for Renal Fibrogenesis—Why and How?
by: Timothy D. Hewitson, et al.
Published: (2021-03-01)